2025
|
P/S
|
Pharmaceutical research services; pharmaceutical products development; pharmaceutical product eva... |
2024
|
P/S
|
pharmaceutical research services; pharmaceutical products development; pharmaceutical product eva... |
|
Invention
|
Therapeutic composition, methods, and uses for the control of seizures.
Described herein are com... |
2023
|
Invention
|
Bumetanide analogs, compositions and methods of use.
The present invention provides bumetanide a... |
|
Invention
|
Pharmaceutical composition.
Described herein is Bumetanide Dibenzylamide, methods for synthesizi... |
|
Invention
|
Therapeutic composition, methods, and uses for the control of seizures. Described herein are comp... |
2022
|
Invention
|
Pharmaceutical composition. Described herein is Bumetanide Dibenzylamide, methods for synthesizin... |
2021
|
Invention
|
Novel pharmaceutical compositions.
The present disclosure relates to novel pharmaceutical compos... |
|
Invention
|
Novel pharmaceutical compositions. The present disclosure relates to novel pharmaceutical composi... |
2018
|
Invention
|
Bumetanide analgos, compositions, and methods of use.
The present invention provides bumetanide ... |
2017
|
Invention
|
Bumetanide analogs, compositions, and methods of use.
The present invention provides bumetanide ... |
2014
|
Invention
|
Bumetanide analogs, compositions and methods of use. A receptor including but not limited to addi... |
2013
|
Invention
|
Analogs and prodrugs of loop diuretics, including bumetanide, furosemide and piretanide; composit... |
|
Invention
|
Analogs and prodrugs of loop diuretics including bumetanide, furosemide and piretanide; compositi... |
|
Invention
|
Analogs and prodrugs of bumetanide; compositions and methods of use.
Novel analogs and prodrugs ... |
2005
|
Invention
|
Methods and compositions for the treatment of neuropsychiatric disorders. − co-transporter is NKCC1. |
|
Invention
|
Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders. − ... |